Imaging and quantification of metastatic melanoma cells in lymph nodes with a ferritin MR reporter in living mice

NMR in Biomedicine

Volumn 25, Issue 5, 2012, Pages 737-745

  Choi, Seung Hong ^a   Cho, Hye Rim ^a   Kim, Hoe Suk ^a   Kim, Young Hwa ^a   Kang, Keon Wook ^a   Kim, Hyeonjin ^a   Moon, Woo Kyung ^a  

^a Seoul National University   (South Korea)

Author keywords

Cellular MRI; Ferritin; Lymph node; Metastasis; Reporter gene

Indexed keywords

CELLULAR TOXICITIES; CONTROL-CELL; CUMULATIVE HISTOGRAM; DEVELOPMENTAL STAGE; FERRITIN; FLUORESCENCE IMAGING; GREEN FLUORESCENT PROTEIN; HEAVY CHAIN; HUMAN FERRITIN; IN-VITRO; IN-VIVO; LYMPH NODE; MELANOMA CELLS; METASTASIS; METASTATIC CANCER CELLS; METASTATIC MELANOMA; NON-INVASIVE IMAGING; NUDE MICE; OVER-EXPRESSION; REPORTER GENE; TARGET ORGANS; TUMOR CELLS;

BODY FLUIDS; CELL CULTURE; DERMATOLOGY; FLUORESCENCE; GENES; MAMMALS; ONCOLOGY; TUMORS; VISUALIZATION;

CELLS;

FERRITIN; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; EX VIVO STUDY; FLUORESCENCE IMAGING; HEAVY CHAIN; HISTOGRAM; HISTOPATHOLOGY; IMAGING AND DISPLAY; IN VITRO STUDY; IN VIVO STUDY; IRON BLOOD LEVEL; LYMPH NODE METASTASIS; MELANOMA; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TUMOR VOLUME;

ANIMALS; APOFERRITINS; CELL LINE, TUMOR; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; TRANSFECTION;

MURINAE; MUS; MUS MUSCULUS;

EID: 84859644480     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1788     Document Type: Article

References (38)

1. Mumprecht V, Detmar M. Lymphangiogenesis and cancer metastasis. J. Cell. Mol. Med. 2009; 13(8A): 1405-1416.
2. Sleeman JP, Thiele W. Tumor metastasis and the lymphatic vasculature. Int. J. Cancer, 2009; 125(12): 2747-2756.
3. Foster PJ, Dunn EA, Karl KE, Snir JA, Nycz CM, Harvey AJ, Pettis RJ. Cellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of mice. Neoplasia, 2008; 10(3): 207-216.
4. Weissleder R Scaling down imaging: molecular mapping of cancer in mice. Nat. Rev. Cancer, 2002; 2(1): 11-18.
5. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001; 19(12): 1141-1147.
6. Zhu J, Zhou L, XingWu F. Tracking neural stem cells in patients with brain trauma. N. Engl. J. Med. 2006; 355(22): 2376-2378.
7. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJ, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JW, Scheenen TW, Punt CJ, Heerschap A, Figdor CG. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005; 23(11): 1407-1413.
8. Heyn C, Ronald JA, Ramadan SS, Snir JA, Barry AM, MacKenzie LT, Mikulis DJ, Palmieri D, Bronder JL, Steeg PS, Yoneda T, MacDonald IC, Chambers AF, Rutt BK, Foster PJ. In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn. Reson. Med. 2006; 56(5): 1001-1010.
9. Song HT, Jordan EK, Lewis BK, Gold E, Liu W, Frank JA. Quantitative T(2)* imaging of metastatic human breast cancer to brain in the nude rat at 3 T. NMR Biomed. 2011; 24(3): 325-334.
10. Winter EM, Hogers B, van der Graaf LM, Gittenberger-de Groot AC, Poelmann RE, van der Weerd L. Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infarcted heart. Magn. Reson. Med. 2010; 63(3): 817-821.
11. Will O, Purkayastha S, Chan C, Athanasiou T, Darzi AW, Gedroyc W, Tekkis PP. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol. 2006; 7(1): 52-60.
12. Cohen B, Ziv K, Plaks V, Israely T, Kalchenko V, Harmelin A, Benjamin LE, Neeman M. MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat. Med. 2007; 13(4): 498-503.
13. Theil EC. Ferritin: at the crossroads of iron and oxygen metabolism. J. Nutr. 2003; 133(5 Suppl 1): 1549S-1553S.
14. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia, 2005; 7(2): 109-117.
15. Genove G, DeMarco U, Xu H, Goins WF, Ahrens ET. A new transgene reporter for invivo magnetic resonance imaging. Nat. Med. 2005; 11(4): 450-454.
16. Deans AE, Wadghiri YZ, Bernas LM, Yu X, Rutt BK, Turnbull DH. Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn. Reson. Med. 2006; 56(1): 51-59.
17. Liu J, Cheng EC, Long RC, Yang SH, Wang L, Cheng PH, Yang J, Wu D, Mao H, Chan AW. Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng. Part C Methods, 2009; 15(4): 739-747.
18. Kim HS, Cho HR, Choi SH, Woo JS, Moon WK. In vivo imaging of tumor transduced with bimodal lentiviral vector encoding human ferritin and green fluorescent protein on a 1.5T clinical magnetic resonance scanner. Cancer Res. 2010; 70(18): 7315-7324.
19. Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A. Magnetic resonance relaxation properties of superparamagnetic particles. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009; 1(3): 299-310.
20. Fidler IJ. Selection of successive tumour lines for metastasis. Nat. New Biol. 1973; 242(118): 148-149.
21. Haacke EM, Filleti CL, Gattu R, Ciulla C, Al-Bashir A, Suryanarayanan K, Li M, Latif Z, DelProposto Z, Sehgal V, Li T, Torquato V, Kanaparti R, Jiang J, Neelavalli J. New algorithm for quantifying vascular changes in dynamic contrast-enhanced MRI independent of absolute T1 values. Magn. Reson. Med. 2007; 58(3): 463-472.
22. Euhus DM, Hudd C, LaRegina MC, Johnson FE. Tumor measurement in the nude mouse. J. Surg. Oncol. 1986; 31(4): 229-234.
23. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 1989; 24(3): 148-154.
24. Long CM, van Laarhoven HW, Bulte JW, Levitsky HI. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res. 2009; 69(7): 3180-3187.
25. Yamauchi K, Yang M, Jiang P, Xu M, Yamamoto N, Tsuchiya H, Tomita K, Moossa AR, Bouvet M, Hoffman RM. Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res. 2006; 66(8): 4208-4214.
26. Yang M, Baranov E, Wang JW, Jiang P, Wang X, Sun FX, Bouvet M, Moossa AR, Penman S, Hoffman RM. Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model. Proc. Nat'l. Acad. Sci. USA, 2002; 99(6): 3824-3829.
27. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer invivo. Nat. Rev. Cancer, 2005; 5(10): 796-806.
28. Troy T, Jekic-McMullen D, Sambucetti L, Rice B. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol. Imaging, 2004; 3(1): 9-23.
29. Tempany CM, McNeil BJ. Advances in biomedical imaging. J. Am. Med. Assoc. 2001; 285(5): 562-567.
30. Weissleder R Molecular imaging in cancer. Science, 2006; 312(5777): 1168-1171.
31. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 2003; 348(25): 2491-2499.
32. Jaffer FA, Weissleder R. Seeing within: molecular imaging of the cardiovascular system. Circ. Res. 2004; 94(4): 433-445.
33. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: invivo role of ferritin ferroxidase activity. J. Biol. Chem. 2000; 275(33): 25 122-25 129.
34. Baldi A, Lombardi D, Russo P, Palescandolo E, De Luca A, Santini D, Baldi F, Rossiello L, Dell'Anna ML, Mastrofrancesco A, Maresca V, Flori E, Natali PG, Picardo M, Paggi MG. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress. Clin. Cancer Res. 2005; 11(9): 3175-3183.
35. Blatt J, Wharton V. Stimulation of growth of neuroblastoma cells by ferritin invitro. J. Lab. Clin. Med. 1992; 119(2): 139-143.
36. Kikyo N, Hagiwara K, Yazaki Y, Okabe T. Growth stimulation of ferritin of human leukemia cells in vitro. J. Cancer Res. Clin. Oncol. 1995; 121(2): 76-78.
37. Kikyo N, Hagiwara K, Fujisawa M, Kikyo N, Yazaki Y, Okabe T. Purification of a cell growth factor from a human lung cancer cell line: its relationship with ferritin. J. Cell. Physiol. 1994; 161(1): 106-110.
38. Ziv K, Meir G, Harmelin A, Shimoni E, Klein E, Neeman M. Ferritin as a reporter gene for MRI: chronic liver over expression of H-ferritin during dietary iron supplementation and aging. NMR Biomed. 2010; 23(5): 523-531.